Clinical Trial: Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531927) titled 'Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy' on March 27.

Brief Summary: Geographic atrophy (GA) is a progressive eye disease that causes the degeneration of the retinal cells, particularly in the macula, leading to vision loss. The goal of this pilot study is to evaluate the safety and the effectiveness of transcorneal electrical stimulation (TES) therapy with the OkuStim 2 System in patients with geographic atrophy (GA).

Researchers will compare the effects of two different electrical stimuli with a placebo to see if the stimuli are safe and can slow down the progression o...